FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Desogestrel and Ethinyl Estradiol Tablets (ORTHO-CEPT)
Status: Discontinuation
»Therapeutic Categories:

Expand all

Janssen Pharmaceuticals (Revised 10/08/2014)

Company Contact Information:
800-526-7736

Presentation Posting Date Related Information
ORTHO-CEPT (NDC 50458-196-15) N/A Product will be delisted. Last distribution March 2015.
ORTHO-CEPT (NDC 50458-196-15) 10/08/2014 Product will be delisted. Last distribution March 2015.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English